Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

More Positive Survival Data in Lung Cancer With Perioperative Therapy

More Positive Survival Data in Lung Cancer With Perioperative Therapy
ShareXFacebook

(MedPage Today) -- SAN DIEGO -- Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with perioperative chemoimmunotherapy, a large randomized trial from China showed. After a median follow...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement